Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppressive Therapy for IgA Nephropathy with Stage 3 or 4 CKD
NCT05510323Phase 3Recruiting
- Sponsor
- Air Force Medical University
- Start
- Feb 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in IgA nephropathy (IgAN), sponsored by Air Force Medical University. Started Feb 2024; status: recruiting.
02
Drugs
cyclophosphamide
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT05510323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05510323.